The Scientific Advisory Committee decided to add a new Working Group on Rare Diseases and Drug Outcomes to the activities of the Genomic Medicine Alliance. This working group will aim to establish collaborative projects among Genomic Medicine Alliance members to elicudate the genetic basis of rare genetic diseases. Also, in conjunction to the Pharmacogenomics Working Group activities, this new Working Group aspires to engage into collaborative projects to delineate genomic variants with rare drug outcomes.

Activities of this new Working Group will be coordinated by Professor Domenica Taruscio (Rome, Italy), who will also participate in the Scientific Advisory Committee of the Genomic Medicine Alliance.